126 related articles for article (PubMed ID: 33371633)
21. Albumin-Bilirubin and Platelet-Albumin-Bilirubin Grades Accurately Predict Overall Survival in High-Risk Patients Undergoing Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma.
Hansmann J; Evers MJ; Bui JT; Lokken RP; Lipnik AJ; Gaba RC; Ray CE
J Vasc Interv Radiol; 2017 Sep; 28(9):1224-1231.e2. PubMed ID: 28688815
[TBL] [Abstract][Full Text] [Related]
22. Using nomogram of the Barcelona Clinic Liver Cancer system for treatment selection in patients with stage C hepatocellular carcinoma.
Hsu CY; Liu PH; Ho SY; Hsia CY; Kudaravalli P; Lee YH; Chiou YY; Tsai YJ; Huang YH; Huo TI
BMC Cancer; 2018 Mar; 18(1):289. PubMed ID: 29540157
[TBL] [Abstract][Full Text] [Related]
23. Transcatheter arterial infusion for advanced hepatocellular carcinoma: Who are candidates?
Suzuki E; Chiba T; Ooka Y; Ogasawara S; Tawada A; Motoyama T; Kanogawa N; Saito T; Yoshikawa M; Yokosuka O
World J Gastroenterol; 2015 Aug; 21(29):8888-93. PubMed ID: 26269678
[TBL] [Abstract][Full Text] [Related]
24. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I
World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792
[TBL] [Abstract][Full Text] [Related]
25. Application of Serum Annexin A3 in Diagnosis, Outcome Prediction and Therapeutic Response Evaluation for Patients with Hepatocellular Carcinoma.
Ma XL; Jiang M; Zhao Y; Wang BL; Shen MN; Zhou Y; Zhang CY; Sun YF; Chen JW; Hu B; Gong ZJ; Zhang X; Cao Y; Pan BS; Zhou J; Fan J; Yang XR; Guo W
Ann Surg Oncol; 2018 Jun; 25(6):1686-1694. PubMed ID: 29626309
[TBL] [Abstract][Full Text] [Related]
26. Polyvinyl alcohol terminal chemoembolization for hepatocellular carcinoma with hepatic arteriovenous shunts: Safety, efficacy, and prognostic factors.
Liu QS; Mei QL; Li YH
Eur J Radiol; 2017 Apr; 89():277-283. PubMed ID: 27908612
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of an artificial intelligence-based clinical trial matching system in Chinese patients with hepatocellular carcinoma: a retrospective study.
Wang K; Cui H; Zhu Y; Hu X; Hong C; Guo Y; An L; Zhang Q; Liu L
BMC Cancer; 2024 Feb; 24(1):246. PubMed ID: 38388861
[TBL] [Abstract][Full Text] [Related]
28. Follow-up schedule for initial recurrent hepatocellular carcinoma after ablation based on risk classification.
Sun X; Li L; Lyu N; Mu L; Lai J; Zhao M
Cancer Imaging; 2020 Jul; 20(1):42. PubMed ID: 32611383
[TBL] [Abstract][Full Text] [Related]
29. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria.
Xu X; Lu D; Ling Q; Wei X; Wu J; Zhou L; Yan S; Wu L; Geng L; Ke Q; Gao F; Tu Z; Wang W; Zhang M; Shen Y; Xie H; Jiang W; Wang H; Zheng S
Gut; 2016 Jun; 65(6):1035-41. PubMed ID: 25804634
[TBL] [Abstract][Full Text] [Related]
30. Degradable starch microspheres versus ethiodol and doxorubicin in transarterial chemoembolization of hepatocellular carcinoma.
Niessen C; Unterpaintner E; Goessmann H; Schlitt HJ; Mueller-Schilling M; Wohlgemuth WA; Stroszczynski C; Wiggermann P
J Vasc Interv Radiol; 2014 Feb; 25(2):240-7. PubMed ID: 24291001
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
Ni JY; Sun HL; Chen YT; Luo JH; Chen D; Jiang XY; Xu LF
World J Gastroenterol; 2014 Dec; 20(46):17483-90. PubMed ID: 25516662
[TBL] [Abstract][Full Text] [Related]
32. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
Yang L; Xu Q; Xie H; Gu G; Jiang J
Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
[TBL] [Abstract][Full Text] [Related]
33. Local recurrence of hepatocellular carcinoma after segmental transarterial chemoembolization: risk estimates based on multiple prognostic factors.
Park SH; Cho YK; Ahn YS; Park YO; Kim JK; Chung JW
Korean J Radiol; 2007; 8(2):111-9. PubMed ID: 17420628
[TBL] [Abstract][Full Text] [Related]
34. A prognostic index for patients within the intermediate stage of hepatocellular carcinoma.
Di Costanzo GG; Signoriello S; Tortora R; Gallo C
Eur J Gastroenterol Hepatol; 2016 May; 28(5):592-8. PubMed ID: 26974431
[TBL] [Abstract][Full Text] [Related]
35. Assessment of preoperative magnetic resonance imaging staging in patients with hepatocellular carcinoma undergoing resection compared with the seventh American Joint Committee on Cancer System.
An C; Choi GH; Lee HS; Kim MJ
Invest Radiol; 2012 Nov; 47(11):634-41. PubMed ID: 22814590
[TBL] [Abstract][Full Text] [Related]
36. The significance of prophylactic transarterial chemoembolization after radical resection of small hepatocellular carcinoma: A retrospective analysis.
Fan S; Yu B; Wang X
J Cancer Res Ther; 2017; 13(5):773-777. PubMed ID: 29237902
[TBL] [Abstract][Full Text] [Related]
37. Preoperative Alfa-Fetoprotein and Fibrinogen Predict Hepatocellular Carcinoma Recurrence After Liver Transplantation Regardless of the Milan Criteria: Model Development with External Validation.
Jiang N; Zeng KN; Dou KF; Lv Y; Zhou J; Li HB; Tang JX; Li JJ; Wang GY; Yi SH; Yi HM; Li H; Chen GH; Yang Y
Cell Physiol Biochem; 2018; 48(1):317-327. PubMed ID: 30016765
[TBL] [Abstract][Full Text] [Related]
38. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
[TBL] [Abstract][Full Text] [Related]
39. [Predictive values of different critical scoring systems for mortality in patients with severe acute respiratory failure supported by extracorporeal membrane oxygenation].
Wang R; Sun B; Li XY; He HY; Tang X; Zhan QY; Tong ZH
Zhonghua Jie He He Hu Xi Za Zhi; 2016 Sep; 39(9):698-703. PubMed ID: 27600419
[TBL] [Abstract][Full Text] [Related]
40. Predicting Survival Using Pretreatment CT for Patients With Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: Comparison of Models Using Radiomics.
Kim J; Choi SJ; Lee SH; Lee HY; Park H
AJR Am J Roentgenol; 2018 Nov; 211(5):1026-1034. PubMed ID: 30240304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
